Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
British Journal of Haematology
|
March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study
Nicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Leukemia
|
December 15, 2019
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Marco Frigeni, Caroline Besson, Carlo Visco, et al.
Hemasphere
|
February 21, 2025
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia
Anna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, et al.
Hemasphere
|
June 7, 2023
SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study
Irene Defrancesco, Virginia Valeria Ferretti, Pierre Morel, et al.
Cancers
|
December 30, 2025
Secondary Genetic Events and Their Relationship to <i>TP53</i> Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)
Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo, et al.
Frontiers in Oncology
|
July 10, 2023
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies
Francesco Angotzi, Marco Petrella, Tamara Berno, et al.
The Oncologist
|
December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli, Marco Frigeni, Laurent Alric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.
The New England Journal of Medicine
|
December 30, 2025
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas
Michele Merli, Elisa Genuardi, Silvia Zibellini, et al.
Hemasphere
|
December 10, 2025
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study
Francesca Maria Quaglia, Annalisa Arcari, Lucia Morello, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
British Journal of Haematology
|
March 9, 2026
Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study
Nicolò Danesin, Francesco Autore, Anna Maria Frustaci, et al.
Leukemia
|
December 15, 2019
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Marco Frigeni, Caroline Besson, Carlo Visco, et al.
Hemasphere
|
February 21, 2025
Salvage treatment after covalent BTKi failure: An unmet need in clinical practice in Waldenstrom macroglobulinemia
Anna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, et al.
Hemasphere
|
June 7, 2023
SARS-CoV-2 Infection in Patients With Waldenström's Macroglobulinemia: A Multicenter International Cohort Study
Irene Defrancesco, Virginia Valeria Ferretti, Pierre Morel, et al.
Cancers
|
December 30, 2025
Secondary Genetic Events and Their Relationship to <i>TP53</i> Mutation in Mantle Cell Lymphoma: A Sub-Study from the FIL_MANTLE-FIRST BIO on Behalf of Fondazione Italiana Linfomi (FIL)
Maria Elena Carazzolo, Francesca Maria Quaglia, Antonino Aparo, et al.
Frontiers in Oncology
|
July 10, 2023
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies
Francesco Angotzi, Marco Petrella, Tamara Berno, et al.
The Oncologist
|
December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli, Marco Frigeni, Laurent Alric, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 23, 2021
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
Grzegorz S Nowakowski, Annalisa Chiappella, Randy D Gascoyne, et al.
The New England Journal of Medicine
|
December 30, 2025
Direct-Acting Antiviral Agents in Hepatitis C-Associated Indolent Lymphomas
Michele Merli, Elisa Genuardi, Silvia Zibellini, et al.
Hemasphere
|
December 10, 2025
The role of time to first progression and fitness status in elderly patients with mantle cell lymphoma: Results from the ELDERLY MANTLE-FIRST study
Francesca Maria Quaglia, Annalisa Arcari, Lucia Morello, et al.
Page
of 21